Microdosing Routines and Self-Tracking: Why Daily Logs Mislead

A daily routine and a self-tracking journal feel like evidence, but they rarely are. Three well-known effects, placebo, regression to the mean and confirmation bias, can make almost any new habit look helpful. That applies to "microdosing" routines too. An honest journal cannot prove a benefit, but it can at least avoid fooling you.

Why Does a New Routine Feel Like It's Working?

Starting any routine changes several things at once. You pay more attention to how you feel. You often sleep, eat or exercise differently. You also expect something to happen. Each of these can shift mood and focus on its own.

Researchers have seen this clearly in psychedelic microdosing. In one of the first systematic studies, Polito and Stevenson tracked 98 people who microdosed psychedelics over six weeks (Polito & Stevenson, PLoS ONE, 2019). They also surveyed 263 people about what they expected. Participants believed microdosing would bring large, wide-ranging benefits. The changes actually reported were narrower, and they did not match the effects people most expected.

That study had no placebo group, so it could not say what caused the changes. But it showed that expectations and outcomes can come apart, and that a daily log can capture both without telling you which is which.

What Are the Three Biases That Distort Self-Tracking?

1. The placebo and expectancy effect. When people expect to feel better, they often do. A 2021 self-blinding study asked 191 people to mix real psilocybin or LSD microdoses with placebo capsules, without knowing which was which (Szigeti et al., eLife, 2021). Both groups improved on every psychological measure over four weeks, with no significant difference between them. A later review explains why expectancy is so hard to control in this field (Szigeti & Heifets, 2024).

2. Regression to the mean. People usually start a new routine when they feel worse than usual. But unusually bad periods tend to be followed by more average ones, whatever you do. Barnett and colleagues describe regression to the mean as "ubiquitous" in repeated measurements and say it should always be considered as a possible cause of an observed change (Barnett, van der Pols & Dobson, International Journal of Epidemiology, 2005). Starting on a bad week almost guarantees apparent improvement.

3. Confirmation bias. We notice and remember information that fits what we already believe. Nickerson's classic review shows this happens across many areas of life, often without awareness (Nickerson, Review of General Psychology, 1998). In a journal, good days get written up in detail and bad days get explained away.

Why Does This Matter More for Amanita Muscaria?

With psilocybin and LSD, researchers can at least run controlled trials and compare against placebo. For Amanita muscaria, no such trials exist. The only way people currently judge it is through personal routines and journals, which are exactly the tools most exposed to these biases.

There is also a safety cost. A journal focused on benefits can miss warning signs. The US Food and Drug Administration concluded in 2024 that Amanita muscaria and its active compounds are not generally recognised as safe in food, and that available data point to adverse effects (FDA Scientific Memorandum, 2024). We explore this in why a journal is a safety record before anything else and in why a microdosing journal can't tell you what you think it can.

How Would an Honest Journal Be Structured?

These principles apply to tracking any wellness change, from a new sleep habit to a diet. They reduce bias, but they cannot turn a personal log into proof.

• Record a baseline first. Track the same measures for several weeks before changing anything, so a bad starting week is not mistaken for your normal.
• Decide your measures in advance. Pick two or three ratings, such as sleep quality or mood on a simple scale, and do not add new ones later because they look promising.
• Log the same time every day. Fixed timing stops you writing more on days you feel strongly.
• Record confounders. Note sleep, alcohol, caffeine, exercise, illness, stress and medication changes.
• Record anything unpleasant. Nausea, dizziness, confusion or low mood belong in the log and are reasons to speak to a doctor.
• Look for the boring explanation first. Before crediting any change, ask whether time, season, workload or expectation could explain it.

Even with all this, a single person's journal remains an uncontrolled observation. It is also worth reading our article on why many listed benefits are measurements that rise on their own.

Frequently Asked Questions

Can a daily journal prove that something works?

No. A journal records changes but cannot separate a substance's effect from placebo, natural ups and downs, or other life changes. Only controlled comparisons can do that.

What is regression to the mean?

It is the tendency for unusually high or low measurements to be followed by more average ones. If you start something on a bad week, you are likely to feel better anyway.

Did placebo-controlled microdosing studies find real benefits?

A 2021 self-blinding study of psilocybin and LSD microdosing found that the placebo group improved as much as the microdose group, with no significant difference.

Has anyone run a controlled study of Amanita muscaria routines?

No. There are no controlled trials of repeated Amanita muscaria use, so personal routines and anecdotes are the only source of claims.

What should a journal always include?

A baseline period, fixed measures chosen in advance, notes on sleep, alcohol, stress and medication, and a record of any unpleasant symptoms, which are a reason to see a doctor.

Disclaimer: This article is educational and is not medical advice. Amanita muscaria is toxic, and Amanita Store does not sell it for human consumption. If you or someone else has symptoms after eating any wild mushroom, contact a doctor, your local poison control centre or emergency services straight away.